CDC Website CDC Website

To Join the NPIN community or

You are here

Commercial Organizations

Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)

NICHD plans to establish new epidemiology cohort(s) of least 2000 participants to stimulate research on a wide range of HIV research hypotheses pertinent to reproductive age women. The purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative epidemiology research in reproductive age women living with HIV.

Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to accelerate development of safe and effective long-acting drug delivery systems (LA-DDS) for improved, simplified treatment of HIV-1 in children. This FOA invites applicants engaged in the development of existing LA-DDS platforms at early product development stages to perform specific preclinical activities that enable product optimization and accelerated translation to HIV-1 infected children. Collaborative research partnerships with industry are required.

Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum

The purpose of this research project is to use medical and pharmacy claims data in real-time to: 1) identify HIV-infected patients who have stopped filling anti-retroviral (ARV) prescriptions and to target these individuals for adherence and retention intervention(s) (Category A); and 2) identify persons living with HIV (including pregnant women) and to ensure these individuals are receiving ARV therapy - Medical and Pharmacy Claims (Category B).

The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)

The purpose of this research project is to develop feasible and effective models for using HIV point-of-care nucleic acid tests: (1) to improve pre-exposure prophylaxis (PrEP) initiation and maintenance among persons at high-risk for acquiring HIV infection; (2) to improve viral suppression among persons diagnosed with HIV infection; and (3) to reduce the time between testing in community-based settings, linkage to HIV care and ART initiation.

The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)

The purpose of this research project is to develop feasible and effective models for using HIV point-of-care nucleic acid tests: (1) to improve pre-exposure prophylaxis (PrEP) initiation and maintenance among persons at high-risk for acquiring HIV infection; (2) to improve viral suppression among persons diagnosed with HIV infection; and (3) to reduce the time between testing in community-based settings, linkage to HIV care and ART initiation.

Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to develop and test strategies to increase the engagement of men in HIV prevention and care within global settings and among US domestic populations who have evidenced lower rates of engagement and retention in HIV prevention and care. This FOA is specifically focused on developing effective strategies to engage and retain men in HIV prevention and care and assessing the impact of these treatment and prevention strategies along the HIV prevention and care continua.

AIDS Education and Training Centers (AETC) National Coordinating Resource Center

This notice announces the opportunity to apply for funding under the AIDS Education and Training Centers (AETC) National Coordinating Resource Center (NCRC), a component of the Ryan White HIV/AIDS Part F AETC Program. The AETC Program consists of the Regional AETC Program, two National AETCs, called the National Clinician Consultation Center (NCCC) and the AETC-NCRC, and an AETC national evaluation contractor (NEC). The Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB), Office of Training and Capacity Development administers this program.

Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support innovative studies to identify and understand the immunological responses that mediate protection from Mycobacterium tuberculosis (Mtb) infection or following vaccination with Bacillus Calmette-Gurin (BCG) or investigational vaccines. Studies may focus on any stage of mycobacterial infection and may include HIV-infected or uninfected individuals. Development of novel functional assays to assess host response and inclusion of immune profiling and systems biology approaches are encouraged.

Pages

Subscribe to RSS - Commercial Organizations